Dazza, I think you're deluding yourself, when you can count the number of organisations researching hair loss treatments on one hand, something kind of tells you its not "5 years away".
7th World Congress for Hair Research (2013)
Collapse
X
-
not sure if linking to another site is aloud tho there is a simular post on Hair site that might be worth a read
http://www.****.com/hair-loss/board_...r&descasc=DESC
just replace the **** with hair site ( minus the space )Comment
-
Comment
-
not sure if linking to another site is aloud tho there is a simular post on Hair site that might be worth a read
http://www.****.com/hair-loss/board_...r&descasc=DESC
just replace the **** with hair site ( minus the space )Comment
-
Comment
-
Comment
-
Comment
-
Pentarou,
1)The swiis/japanese company product manager approached me for mini clinical trial of their topical CG210 alone or in conjunction with oral or topical finasteride foam.They provided me with few samples.
Can only tell about it's efficacy after using the same.
2)P-3074 a topical 0.25%finasteride with special delivery vehicle called HYDROXYPROPYL CHITOSAN(HPCH),a film forming agent,with single daily topical dosage showed reduction in scalpDHT by 71.2% as against oral finasteride which showed reduction of scalp DHT by 51.1% with equal period of therapy.
With Annika Vogt coming up with nano particulate and virus like targetted delivery vehicles(to every aspect of follicle ,including stemcells)..oral finasteride will be in the grave yard soon..and it's systemic sexual side effects could be avoided.Comment
-
Dr Nigam we really apreciate your effort,
we all thank you , we hope we ll talk about these in detail soonComment
-
Pentarou,
1)The swiis/japanese company product manager approached me for mini clinical trial of their topical CG210 alone or in conjunction with oral or topical finasteride foam.They provided me with few samples.
Can only tell about it's efficacy after using the same.
2)P-3074 a topical 0.25%finasteride with special delivery vehicle called HYDROXYPROPYL CHITOSAN(HPCH),a film forming agent,with single daily topical dosage showed reduction in scalpDHT by 71.2% as against oral finasteride which showed reduction of scalp DHT by 51.1% with equal period of therapy.
With Annika Vogt coming up with nano particulate and virus like targetted delivery vehicles(to every aspect of follicle ,including stemcells)..oral finasteride will be in the grave yard soon..and it's systemic sexual side effects could be avoided.
Of course toxicity in case of fina load is not that much of an issue but still, if the biodegredability kinetics aren't right, it's not going to improve thingsComment
-
As always, you're exaggerating things. Sure, nanoparticle assisted drug delivery is going to be one of the biggest pharma breakthroughs of this decennium but not 'soon' as in next year. Very interesting progress is currently being made, one of the biggest concerns of course was the toxicity of the particles, so bio-degradability is key and just yesterday this awesome news came out: http://www.sciencedaily.com/releases...0507115506.htm however research here is still pre-clinical. By the time nano particle assisted drug delivery is a main stream thing, we'll hopefully have a real cure like Team Tokyo's available as well.
The nanotech these biotechnology professionals are talking about are the same technology they currently use in a number of skin creams such as most famously sun lotion which reduces systemic absorbtion/side effects.
Whats the point?Comment
Comment